The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia
出版年份 2015 全文链接
标题
The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia
作者
关键词
-
出版物
LEUKEMIA
Volume 30, Issue 4, Pages 800-811
出版商
Springer Nature
发表日期
2015-12-01
DOI
10.1038/leu.2015.327
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD
- (2014) A. Khoder et al. BLOOD
- A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta
- (2014) Hae mi Lee et al. CELLULAR IMMUNOLOGY
- c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells
- (2014) Rosa Molfetta et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
- (2014) K. Stringaris et al. HAEMATOLOGICA
- Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells
- (2014) G. F. Torelli et al. HAEMATOLOGICA
- The Incognito Journey of a Regulatory B Cell
- (2014) Claudia Mauri et al. IMMUNITY
- TGF- Utilizes SMAD3 to Inhibit CD16-Mediated IFN- Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells
- (2014) R. Trotta et al. JOURNAL OF IMMUNOLOGY
- Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia--Implications for Immunotherapy
- (2013) G. Weber et al. CLINICAL CANCER RESEARCH
- Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy
- (2013) Bo Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Neuroblastoma-Derived TGF- 1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
- (2013) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
- (2012) Stephen P. Hunger et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
- (2012) D J DiLillo et al. LEUKEMIA
- Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands
- (2012) Laura Jardine et al. LEUKEMIA & LYMPHOMA
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- Tumor Induced Inactivation of Natural Killer Cell Cytotoxic Function; Implication in Growth, Expansion and Differentiation of Cancer Stem Cells
- (2012) Anahid Jewett et al. Journal of Cancer
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- IL-18 Induces PD-1-Dependent Immunosuppression in Cancer
- (2011) M. Terme et al. CANCER RESEARCH
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function
- (2010) Moshe Elkabets et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started